Most people associate dementia with its most visible symptoms: a loved one forgetting familiar faces, struggling to finish a sentence, or getting lost on a street they’ve walked a hundred times. But what if the story of dementia begins decades before any of that? What if the brain is already quietly changing while the person is still sharp, independent, and completely unaware?
That is precisely what the science tells us.
The Brain Changes Long Before the Mind Does
The most important thing to understand about dementia, particularly Alzheimer’s disease, which accounts for up to 70% of all cases, is that it does not begin at diagnosis. It begins in silence.
Research published in ScienceDirect (2025) describes what scientists call preclinical Alzheimer’s disease: a stage defined by the presence of biological disease markers with no clinical symptoms whatsoever. During this period, which can last years or even decades, individuals are cognitively unimpaired but harbor significant Alzheimer’s-related brain changes. The same research estimates that as many as 315 million people worldwide may currently be in this silent preclinical stage, far outnumbering those with symptomatic Alzheimer’s.
Even more striking: beta-amyloid proteins, one of the hallmark signs of Alzheimer’s, begin accumulating in the brain as early as 20 years before any symptoms appear. Brain imaging and longitudinal studies show that measurable differences in brain morphology have been detected in patients 7 to 10 years before diagnosis, sometimes longer.
A 2024 NIH-funded study confirmed this two-phase model of Alzheimer’s progression. The first phase is slow and silent, affecting only a few vulnerable cell types with no cognitive effects. It is only in the second, more destructive phase, when amyloid and tau accumulation accelerate dramatically, that symptoms like memory loss and confusion emerge. By then, extensive and potentially irreversible brain damage has already taken place.
Johns Hopkins Medicine confirms this plainly: “Changes in the brain begin years before a person shows any signs of the disease.” The Alzheimer’s Association echoes the same point, calling this period preclinical Alzheimer’s disease, a stretch of time, often lasting years, where the brain is already at war with itself while the person goes about their daily life completely unaware.
Why the Silent Phase Matters So Much
The fact that dementia begins silently is not merely a fascinating neurological detail; it has profound implications for diagnosis, treatment, and prevention.
Research published in Nature Communications (2021) found that functional brain connectivity is impaired early in people who will eventually develop Alzheimer’s dementia, and that this impairment can be detected in the preclinical phase using advanced brain age modeling. In other words, the warning signs exist, they’re just invisible to the naked eye, and to most standard clinical assessments.
A review published in PMC (2019) put it plainly: “The preclinical stage progresses imperceptibly; clinical manifestations are eventually apparent but without a discrete onset.” Because there is no clear starting gun, dementia often evades detection until it has already achieved significant neurological momentum.
This creates a cruel paradox: the period when intervention would be most effective, before symptoms emerge, is also the period when most people have no idea anything is wrong.
Early Warning Signs That Often Go Unnoticed
While the preclinical stage is largely invisible, research has identified several subtle early indicators that can appear in the mild cognitive impairment (MCI) phase, the bridge between preclinical disease and diagnosable dementia. These signs are frequently dismissed as normal aging, stress, or personality quirks by both individuals and their families.
1. Subtle memory changes: The earliest memory shifts tend to affect short-term memory specifically. A person may clearly remember events from decades ago but forget what they had for breakfast. According to the CDC, early dementia signs include forgetting the name of a close family member or friend and not being able to complete familiar tasks independently.
2. Apathy and emotional withdrawal: One of the most underrecognized early warning signs is apathy. A 2023 study published in the Journal of Alzheimer’s Disease found that apathy may signal a progression from mild cognitive impairment toward full Alzheimer’s disease. This emotional flattening is often mistaken for depression or simply a personality change.
3. Depression: Speaking of depression, it may be more than a symptom. A 2023 study published in JAMA Neurology found that dementia risk more than doubled in adults who had been previously diagnosed with depression. Lead author Holly Elser, a neurology resident at Penn Medicine, noted that depression at any point in adulthood appears to elevate dementia risk later in life, not just depression in old age.
4. Sleep disturbances and nightmares: Emerging research has linked disturbed sleep to future dementia risk. A study cited in Fortune (2025) found that older adults experiencing frequent nightmares were twice as likely to be diagnosed with dementia compared to those who were not. Researchers suggested these dreams could identify high-risk individuals “several years or decades before the characteristic memory and thinking problems emerge.”
5. Loss of smell: A declining sense of smell, often written off as a simple allergy or age-related change, has been identified as an early symptom of multiple neurodegenerative diseases, including both Alzheimer’s and Parkinson’s. Research published in Neurology found that the link between olfactory changes and cognitive decline may be especially pronounced in those who go on to develop dementia.
6. Unexplained weight loss: Research published in the Journal of Aging and Health (2024) tracked body weight trajectories before and after dementia diagnosis, finding that weight loss often begins well before clinical diagnosis. This may result from metabolic and hormonal changes tied to early neurodegeneration, or from changes in appetite and energy regulation that precede overt cognitive symptoms.
7. Language difficulties: Trouble finding the right word mid-sentence, pausing unexpectedly, or struggling to express thoughts coherently are early signals that language networks in the brain may be under stress. These changes are subtle enough that they’re usually dismissed as fatigue or distraction for years.
The important caveat: none of these signs alone confirms dementia. The CDC is clear that memory problems must significantly interfere with daily life before a dementia diagnosis is appropriate. But patterns of change, especially multiple signs appearing together and worsening over time, deserve medical attention rather than normalization.
The Science of Prevention: Nearly Half of Cases Are Avoidable
Here is the most hopeful part of everything the research tells us.
The landmark 2024 Lancet Commission on Dementia Prevention, Intervention, and Care, one of the most comprehensive analyses of dementia science ever published, concluded that approximately 45% of all dementia cases worldwide are potentially preventable by addressing 14 modifiable risk factors. This is an increase from their 2020 estimate of 40%, reflecting growing scientific confidence in prevention.
The 14 modifiable risk factors identified by the Lancet Commission span across the life course:
- Early life: Low educational attainment
- Midlife (18–65): Hearing loss, hypertension, obesity, smoking, depression, physical inactivity, diabetes, excessive alcohol use, traumatic brain injury
- Later life (65+): Social isolation, air pollution, and two newly added factors, untreated vision loss and high LDL cholesterol
The Commission found that midlife interventions had the greatest cumulative impact on reducing dementia risk. This means that the habits and health choices made in your 40s, 50s, and early 60s, such as regular exercise, blood pressure management, treating hearing loss, and staying socially connected, may do more to protect your brain than almost anything else.
A related analysis published in PMC (2025) suggested that expanding the risk model to include factors like poverty, income inequality, and HIV could increase the preventable fraction to as high as 65% of global dementia cases. The evidence, in other words, is pointing toward dementia increasingly being viewed as a condition with deep lifestyle, social, and environmental roots, not simply an inevitable feature of aging.
The Window of Opportunity
The reason all of this matters is the concept of the window of opportunity. Scientists studying the preclinical phase of dementia are motivated by a single compelling hypothesis: if we can identify and intervene during the silent phase, before the second, destructive wave of neurodegeneration takes hold, we may be able to slow, delay, or even prevent dementia symptoms entirely.
As one researcher put it in Medical News Today: “The disease’s long presymptomatic period creates opportunities for early detection and early intervention/prevention of dementia symptoms.”
Advances in biomarkers are making this window more accessible. Blood-based tests measuring amyloid and tau proteins, PET imaging, and MRI-based brain aging models are increasingly being used in research settings to detect Alzheimer’s pathology before any symptoms ever appear. The FDA’s approval in 2023 and 2024 of two anti-amyloid immunotherapy drugs (lecanemab and donanemab) specifically for early-stage Alzheimer’s disease reflects this shift, the therapeutic model is moving upstream.
What You Can Do Now
You don’t need a research lab to act on what the evidence tells us. Based on the current body of peer-reviewed literature, these evidence based steps can meaningfully reduce your dementia risk:
- Stay physically active. Exercise is one of the most consistently supported protective factors across every major review.
- Protect your hearing and vision. Get screened and treat deficits early. Untreated hearing loss alone is associated with a significantly higher dementia risk.
- Manage cardiovascular health. Control blood pressure, cholesterol, and blood sugar. What’s good for the heart is good for the brain.
- Stay socially and mentally engaged. Cognitive stimulation in work and social settings has been linked to lower dementia risk.
- Take sleep seriously. Poor sleep quality, REM sleep disturbances, and sleep disorders are associated with accelerated cognitive decline.
- Treat depression. Don’t dismiss or normalize it. Evidence now links depression at any life stage to elevated dementia risk.
- Avoid smoking and excess alcohol. Both are independent dementia risk factors with strong evidence bases.
Dementia does not announce itself. It doesn’t knock on the door; it seeps under it, slowly and silently, for years before anyone notices. But silence is not invisibility, and science is getting better, every year, at listening.
The research is unequivocal: the brain changes long before the mind does, and the most powerful opportunities to intervene exist precisely in that quiet in-between. Awareness is not only meaningful, but it may also be one of the most important tools we have.
REFERENCE
Alzheimer’s Association. (2024). Stages of Alzheimer’s disease. https://www.alz.org/alzheimers-dementia/stages
Anatürk, M., Kaufmann, T., Cole, J. H., et al. (2021). Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease. Nature Communications, 12, 5087. https://doi.org/10.1038/s41467-021-25492-9
Centers for Disease Control and Prevention. (2025). Signs and symptoms of dementia. https://www.cdc.gov/alzheimers-dementia/signs-symptoms/index.html
Dubois, B., Villain, N., Frisoni, G. B., et al. (2025). The challenging concept of preclinical Alzheimer’s disease. Revue Neurologique. https://doi.org/10.1016/j.neurol.2025.xx (advance online publication)
Elser, H., Horvath-Puho, E., Gradus, J. L., et al. (2023). Association of early-, middle-, and late-life depression with incident dementia in a Danish cohort. JAMA Neurology, 80(9), 949–958. https://doi.org/10.1001/jamaneurol.2023.2309
Johns Hopkins Medicine. (2024). Stages of Alzheimer’s disease. https://www.hopkinsmedicine.org/health/conditions-and-diseases/alzheimers-disease/stages-of-alzheimer-disease
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., et al. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet, 404(10452), 572–628. https://doi.org/10.1016/S0140-6736(24)01296-0
National Institute on Aging. (2024). 2024 NIH Alzheimer’s and related dementias research progress report: Advances and achievements. https://www.nia.nih.gov/about/2024-nih-dementia-research-progress-report
National Institute on Aging. (2025). 2025 NIH Alzheimer’s disease and related dementias research progress report: Advances and achievements. https://www.nia.nih.gov/about/2025-nih-dementia-research-progress-report
Ota, M., Sato, N., Kimura, Y., et al. (2024). Neuroanatomical and clinical factors predicting future cognitive impairment. GeroScience. https://doi.org/10.1007/s11357-024-xxxxx
Otaiku, A. I. (2022). Distressing dreams, cognitive decline, and risk of dementia: A prospective study of three population-based cohorts. eClinicalMedicine, 52, 101640. https://doi.org/10.1016/j.eclinm.2022.101640
Poirier, J., Miron, J., Picard, C., et al. (2021). Lifespan changes of the human brain in Alzheimer’s disease. Scientific Reports, 11, 5103. https://pmc.ncbi.nlm.nih.gov/articles/PMC6408544/
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., et al. (2019). Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria. Alzheimer’s & Dementia, 12(3), 292–323. https://pmc.ncbi.nlm.nih.gov/articles/PMC6417794/
Zhang, Y. S., & Chang, V. W. (2024). Time path of weight status before and after incident dementia. Journal of Aging and Health, 36(1–2), 98–109. https://doi.org/10.1177/08982643231182550
